#1 Clinical Trials Search in Europe

Gadoteridol

Gadoteridol, also known by the brand name ProHance, is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance image quality and improve diagnostic accuracy. This article explores the use of gadoteridol in various clinical trials, focusing on its effectiveness, safety, and applications in different medical conditions, particularly in neurological imaging.

Table of Contents

What is Gadoteridol?

Gadoteridol, also known by its brand name ProHance, is a type of contrast agent used in magnetic resonance imaging (MRI) scans[1]. Contrast agents are substances given to patients before or during an MRI to help make certain parts of the body show up more clearly on the images. Gadoteridol belongs to a class of contrast agents called gadolinium-based contrast agents (GBCAs)[2].

How Gadoteridol Works

Gadoteridol contains a rare earth element called gadolinium. When injected into the bloodstream, it circulates throughout the body and temporarily changes the magnetic properties of tissues. This allows the MRI scanner to create clearer and more detailed images of organs, blood vessels, and other structures inside the body[3].

Uses of Gadoteridol

Gadoteridol is primarily used to enhance MRI scans of the central nervous system (CNS), which includes the brain and spinal cord. It helps doctors detect and evaluate various conditions, such as:

  • Brain metastases: Cancerous tumors that have spread to the brain from other parts of the body[4]
  • Multiple sclerosis (MS): A disease that affects the nervous system and can cause various neurological symptoms[5]
  • Other brain and spinal cord disorders: Including tumors, infections, and inflammatory conditions[6]

Gadoteridol can also be used for MRI scans of other parts of the body, such as the chest, abdomen, and pelvis, to help diagnose various conditions[2].

Administration and Dosage

Gadoteridol is typically given as an intravenous (IV) injection, which means it is injected directly into a vein. The standard dose is usually 0.1 mmol per kilogram of body weight. In some cases, a higher dose of 0.2 mmol/kg may be used[4]. The exact dose and timing of the injection may vary depending on the specific type of MRI scan being performed and the patient’s individual needs.

Safety and Side Effects

Gadoteridol is generally considered safe for most patients. However, like all medications, it can cause side effects in some people. Common side effects may include:

  • Headache
  • Nausea
  • Dizziness
  • Injection site reactions (such as pain or warmth)

Serious allergic reactions are rare but can occur. Patients with a history of allergies or kidney problems should inform their doctor before receiving gadoteridol[6].

Comparison to Other Contrast Agents

Several studies have compared gadoteridol to other gadolinium-based contrast agents, such as gadobutrol (Gadavist/Gadovist) and gadoquatrane. These studies aim to evaluate the effectiveness and safety of different contrast agents for various MRI applications[3][2].

Some key points from these comparisons include:

  • Gadoteridol and gadobutrol have shown similar effectiveness in enhancing MRI images of brain tumors[3].
  • Newer contrast agents, like gadoquatrane, are being developed with the goal of using lower doses of gadolinium while maintaining image quality[2].
  • The choice of contrast agent may depend on factors such as the specific body part being imaged, the patient’s medical history, and the preference of the radiologist or healthcare provider.

Ongoing Research

Researchers continue to study gadoteridol and other contrast agents to improve MRI techniques and expand their applications. Some areas of ongoing research include:

  • Pediatric use: Evaluating the safety and effectiveness of gadoteridol in children under 2 years old[6].
  • Multiple sclerosis: Using gadoteridol to study blood flow changes in the brains of MS patients[5].
  • Brain metastases: Comparing different doses of gadoteridol for detecting and evaluating brain metastases[4].
  • New delivery methods: Investigating techniques like convection-enhanced delivery to administer contrast agents directly to brain tumors[7].

These ongoing studies aim to improve the diagnosis and treatment of various medical conditions using advanced imaging techniques with gadoteridol and other contrast agents.

Aspect Details
Primary Uses Enhancing MRI imaging for brain, spine, and whole-body scans
Key Conditions Studied Brain metastases, multiple sclerosis, central nervous system diseases
Dosage Typically 0.1 mmol/kg body weight, administered intravenously
Comparative Efficacy Comparable to other gadolinium-based contrast agents like gadobutrol
Safety Profile Generally well-tolerated; ongoing studies in pediatric populations
Imaging Parameters Improved Contrast enhancement, border delineation, internal morphology of lesions
Clinical Benefits Enhanced lesion detection, improved diagnostic confidence, better treatment planning
Ongoing Research Use in various body regions, optimization of dosing, long-term safety

FAQ

  • What is gadoteridol and how is it used? Gadoteridol is a gadolinium-based contrast agent used in MRI scans. It is injected intravenously to enhance image quality, allowing for better visualization of abnormalities in the brain, spine, and other body parts. It helps doctors detect and characterize lesions, tumors, and other pathological conditions more accurately.
  • How does gadoteridol compare to other contrast agents? Clinical trials have shown that gadoteridol is comparable in efficacy to other gadolinium-based contrast agents like gadobutrol. For example, in a study comparing ProHance (gadoteridol) with Gadovist/Gadavist (gadobutrol), both agents demonstrated similar overall technical and diagnostic performance in brain tumor imaging.
  • Is gadoteridol safe for use in children? Gadoteridol has been studied for use in pediatric patients. A safety and efficacy study was conducted in children younger than 2 years of age who underwent brain or spine MRI with ProHance administration. However, as with any medical procedure, the use of contrast agents in children should be carefully considered and monitored.
  • What are the potential side effects of gadoteridol? While gadoteridol is generally well-tolerated, like all medications, it can have side effects. Clinical trials monitor for adverse events, which can include mild reactions such as headache or nausea. Serious allergic reactions are rare but possible. Always inform your healthcare provider of any unusual symptoms after receiving a contrast agent.
  • In which medical conditions is gadoteridol being studied? Gadoteridol is being studied in various conditions, particularly those affecting the central nervous system. Clinical trials have investigated its use in brain metastases, multiple sclerosis, and other neurological disorders. It's also being evaluated for whole-body MRI applications to detect or characterize lesions outside the brain and spine.

Ongoing Clinical Trials on Gadoteridol

  • Study of AAV2-GDNF for Adults with Moderate Parkinson’s Disease Using a Drug Combination

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland

  • A study to optimize the delivery of AAV2-GDNF and gadoteridol into the brain for patients with Parkinson’s disease

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on the Long-Term Effects of Gadoxetic Acid, Gadoteridol, and Gadobenate Dimeglumine on Motor and Cognitive Functions in Healthy Adults

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy

  • Study Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia France Germany Hungary Italy +1

  • Study Comparing Gadoquatrane with Gadoteric Acid, Gadoteridol, and Gadobutrol for MRI in Patients with Non-CNS Conditions

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia France Germany Hungary Italy +2

Glossary

  • Gadoteridol: A gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to enhance image quality and improve diagnostic accuracy, particularly in neurological imaging.
  • MRI (Magnetic Resonance Imaging): A non-invasive imaging technique that uses strong magnetic fields and radio waves to create detailed images of the body's internal structures.
  • Contrast agent: A substance administered to patients before or during imaging procedures to enhance the visibility of specific tissues or abnormalities.
  • Gadolinium: A rare earth element used in contrast agents for MRI due to its magnetic properties that enhance image contrast.
  • Central Nervous System (CNS): The part of the nervous system consisting of the brain and spinal cord.
  • Lesion: An area of abnormal tissue or injury visible on imaging studies.
  • Metastasis: The spread of cancer cells from the primary site to other parts of the body, often forming secondary tumors.
  • Blinded reader: An expert who evaluates medical images without knowledge of the patient's clinical information or the specific contrast agent used, to ensure unbiased assessment.
  • Efficacy: The ability of a treatment or intervention to produce the desired result.
  • Adverse event: Any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medical treatment or procedure.

References

  1. https://clinicaltrials.gov/study/NCT00709852
  2. https://clinicaltrials.gov/study/NCT05915728
  3. https://clinicaltrials.gov/study/NCT01613417
  4. https://clinicaltrials.gov/study/NCT00522951
  5. https://clinicaltrials.gov/study/NCT02481882
  6. https://clinicaltrials.gov/study/NCT03750188
  7. https://clinicaltrials.gov/study/NCT04608812